Literature DB >> 12630547

Myocardial protection: entering the new millennium.

Gerald D Buckberg1.   

Abstract

Dual objectives at operation are technical success and absence of iatrogenic injury due to inadequate myocardial protection. We enter a new millennium, and the spectrum of surgical procedures used to correct abnormal structure is expanding. We need longer intervals of aortic clamping to make the correct diagnosis, and to implement a more natural correction (i.e., mitral valve repair, Ross procedure, aortic recontruction with stentless valves, homografts). Simultaneously, our patients have increased vulnerability to injury, so that growth is needed to advance our methods of protection, in the same way as we learn new operative techniques. This manuscript deals both with evolution of current methods and recognition of newer methods of protection, so that the dual relationship between protection and procedures will not separate.

Entities:  

Mesh:

Year:  2002        PMID: 12630547     DOI: 10.1111/j.1540-8191.2001.tb01176.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  3 in total

1.  Early Left and Right Ventricular Response to Aortic Valve Replacement.

Authors:  Andra E Duncan; Sheryar Sarwar; Babak Kateby Kashy; Abraham Sonny; Shiva Sale; Andrej Alfirevic; Dongsheng Yang; James D Thomas; Marc Gillinov; Daniel I Sessler
Journal:  Anesth Analg       Date:  2017-02       Impact factor: 5.108

2.  Comparison of effects of sevoflurane versus propofol on left ventricular longitudinal global and regional strain in patients undergoing on-pump coronary artery bypass grafting.

Authors:  G N Chennakeshavallu; Shrinivas Gadhinglajkar; Rupa Sreedhar; Saravana Babu; Sruthi Sankar; Prasanta Kumar Dash
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

3.  High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery.

Authors:  Emel Fatma Kocak; Cengiz Kocak; Ahmet Aksoy; Ozden Ozben Isiklar; Raziye Akcilar; Ibrahim Fevzi Ozdomanic; Cevher Unsal; Merve Celenk; Irfan Altuntas
Journal:  Cardiovasc J Afr       Date:  2015-07-14       Impact factor: 1.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.